James Allison, PhD
Nobel Laureate, Chair of Immunology, MD Anderson Cancer Center, University of Texas
Dr. James Allison is an American immunologist and Nobel laureate who holds the position of Professor and Chair of Immunology, and Executive Director of Immunotherapy Platform at the MD Anderson Cancer Center at the University of Texas. Dr. Allison has spent his career studying the regulation of T cell responses and developing strategies for cancer immunotherapy. He earned the 2018 Nobel Prize in Physiology or Medicine, which he shared with Dr. Tasuku Honjo “for their discovery of cancer therapy by inhibitions of negative immune regulation.” His discoveries have led to new cancer treatments for some of the deadliest cancers. He is the Director of the Cancer Research Institute (CRI) Scientific Advisory Council. Among his many honors, Dr. Allison is a member of the National Academies of Science and Medicine and received the Lasker-Debakey Clinical Medical Research Award in 2015. His current work seeks to improve immune checkpoint blockade therapies currently used by clinicians and identify new targets to unleash the immune system to eradicate cancer.
Contact Person For:
